Aevice Health Secures $7 Million in Seed Funding to Advance Remote Respiratory Monitoring Technology

Aevice Health Pte Ltd, a pioneering MedTech firm based in Singapore and a spin-off from Nanyang Technological University, has successfully raised an impressive $7 million in funding. This significant investment marks a substantial milestone in the company's mission to combat chronic respiratory diseases—one of the most pressing healthcare issues of our time. Aevice Health is at the forefront of innovation with its state-of-the-art, non-invasive wearable devices that facilitate the early detection of cardiopulmonary abnormalities. This unique technology empowers patients to receive real-time, remote monitoring and care, ensuring timely and targeted interventions from the comfort of their own homes. Coupled with the Aevice analytical platform, healthcare professionals can easily access vital insights into their patients' health, enabling them to effectively track treatment responses and improve healthcare outcomes. The recent funding will be instrumental in expanding Aevice Health’s research and development capabilities, further enhancing its product offerings and broadening its reach in the global healthcare market. By driving medical innovations that not only transform healthcare but also elevate patient empowerment, Aevice Health is poised to make a significant impact in the lives of many individuals living with chronic respiratory conditions. For more information about our groundbreaking efforts, please visit www.aevice.com.